The calcium, Calcitriol, Vitamin K2-7 is medically approved to treat nutritional deficiencies, osteoporosis (weak and brittle bone), osteomalacia (Rickets), calcium deficiency, hypoparathyroidism (low level of parathyroid hormone).

It helps to treat nutritional deficiencies, osteoporosis (weak and brittle bone), osteomalacia (Rickets), calcium deficiency, hypoparathyroidism (low level of parathyroid hormone).

Calcium, Calcitriol, Vitamin K2-7 should be taken as directed by your physician. It may be taken with or without food. Swallow the whole with a glass of water. Avoid chewing, breaking, or crushing the tablet. 

The common side effects that are experienced while you are on the treatment with Calcium Calcitriol, Vitamin K2-7 are constipation, stomach upset, headache, nausea, vomiting, loss of appetite, mood changes, fast heartbeat, muscle pain, weakness or tiredness.

Inform your doctor if any of these symptoms disturb you or persist. Inform your doctor if you experience hypersensitivity to calcium, calcitriol, vitamin K2-7, or any of its ingredients. 

Before treatment commences with this medication, let your physician know if you have kidney stones, hypervitaminosis D (high vitamin D levels), hypercalcemia (high calcium levels), malabsorption syndrome, heart, liver, or kidney disease. Consult your healthcare provider if you are a pregnant or breastfeeding woman. This medication should be given to children when prescribed by a doctor. 

It is recommended that you avoid drinking alcohol while using Calcium, Calcitriol, Vitamin K2-7 since it can interfere with calcium absorption. It is advised to regularly check heart function and serum electrolyte levels. A low-phosphate diet is advised for dialysis patients to manage their serum phosphorus levels.Drink an adequate amount of water when taking calcium calcitriol, vitamin K2-7 as proper hydration is important for optimal absorption and utilization of calcium in the body.

1.  Roche Laboratories Inc., US Food & Drug Administration, [Revised on Nov 1998] [Accessed on 18 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/21068lbl.pdf
2. Accord UK Limited., Electronic medicines compendium (EMC), [Revised on Sep 2019] [Accessed on 18 Nov 2022], https://www.medicines.org.uk/emc/product/12544/smpc#gref
3. KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting calcium balance, 7th Edition, 2013, 335-345.

The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.